mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy
Crossref DOI link: https://doi.org/10.1186/s12951-017-0302-5
Published Online: 2017-10-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zheng, Yan
Su, Chang
Zhao, Liang
Shi, Yijie
Funding for this research was provided by:
National Natural Science Foundation of China (81641167)